Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Natural polymorphisms of integrase among HIV type 1-infected South African patients.

AIDS research and human retroviruses - 1 Apr 2010

Fish Muhammad Q, Hewer Raymond, Wallis Carole L, Venter Willem D F, Stevens Wendy S, Papathanasopoulos Maria A

Abstract excerpt

An HIV-1 subtype C specific assay was established for integrase genotyping from 51 integrase inhibitor-naive patient plasma samples and 22 antiretroviral drug-naive primary viral isolates from South Africa. Seventy-one of the 73 samples were classified as HIV-1 subtype C and two samples were unique AC and CG recombinants in integrase. Amino acid sequence analysis revealed there were no primary mutations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Multiple, Viral
Share to HIV Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Integrase

Share to HIV Integrase Inhibitors

Share to Pyrrolidinones

Share to Quinolones

Share to Raltegravir Potassium

Share to South Africa

Source

Identifiers

PMID: 20377427
DOI: 10.1089/aid.2009.0249

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Natural polymorphisms of integrase among HIV type 1-infected South African patients.PMID 20377427Read ↗

Analyses of HIV-1 integrase gene sequences among treatment-naive patients in the Eastern Cape, South Africa.Semantic proximity Read ↗

Analysis of HIV-1 integrase genotypes and polymorphisms among integrase inhibitors-based antiretroviral treatment naïve patients in South Sudan.Semantic proximity Read ↗

Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study.Semantic proximity Read ↗

Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and available of integrase inhibitors in Cape Town, South Africa.Semantic proximity Read ↗

Drug resistance mutations of HIV type 1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-saharan countries and discordant interpretations.Semantic proximity Read ↗

Natural Polymorphisms of Human Immunodeficiency Virus Type 1 Integrase and Inherent Susceptibilities to a Panel of Integrase InhibitorsSemantic proximity Read ↗

Characterization of human immunodeficiency virus type 1 from a previously unexplored region of South Africa with a high HIV prevalence.Semantic proximity Read ↗

Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitors.Semantic proximity Read ↗

HIV Type 1 genetic diversity and naturally occurring polymorphisms in HIV type 1 Kenyan isolates: implications for integrase inhibitors.Semantic proximity Read ↗

Molecular epidemiology of HIV in two highly endemic areas of northeastern South Africa.Semantic proximity Read ↗

Structural effects of HIV-1 subtype C integrase mutations on the activity of integrase strand transfer inhibitors in South African patients.Semantic proximity Read ↗

Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.